(redirected from esmolol hydrochloride)
Also found in: Thesaurus, Medical.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Brevibloc - intravenous beta blocker (trade name Brevibloc) that acts for only a short time; used primarily for cardiac arrhythmias
beta blocker, beta-adrenergic blocker, beta-adrenergic blocking agent, beta-blocking agent - any of various drugs used in treating hypertension or arrhythmia; decreases force and rate of heart contractions by blocking beta-adrenergic receptors of the autonomic nervous system
brand, brand name, marque, trade name - a name given to a product or service
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
The Company's portfolio of approved and marketed brands includes: Xydalba (dalbavancin hydrochloride), for the treatment of acute bacterial skin and skin structure infections (ABSSSI); Zevtera/Mabelio (ceftobiprole medocaril sodium), a cephalosporin antibiotic for the treatment of community- and hospital-acquired pneumonia (CAP, HAP); Brinavess (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm; Aggrastat (tirofiban hydrochloride) for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, and Esmocard and Esmocard Lyo (esmolol hydrochloride), a short-acting betablocker used to control rapid heart rate in a number of cardiovascular indications.
Selvaraj et al [20] in their study concluded that dexmedetomidine is more effective in attenuating the haemodynamic response to oral endotracheal intubation compared to that of esmolol hydrochloride. They found that both dexmedetomidine and esmolol produced a significant reduction in the values of the studied parameters (HR, SBP, DBP, MAP) after intubation.
Mylan has launched esmolol hydrochloride in sodium chloride injection, 2,500 mg/250 mL (10 mg/mL) single-dose plastic bag and 2,000 mg/100 mL (20 mg/mL) single-dose plastic bag, the first generic version of the reference listed drug, Baxter's Brevibloc.
* Group B (study) patients received 0.5 mg/kg body weight of esmolol hydrochloride (made up to 5 mL with normal saline), intravenously over 60 s
A [sz]1-receptor blocker was used (esmolol hydrochloride injection, Qilu Pharmaceutical, Jinan, China) to control HR.